PDL BioPharma to Participate at 31st Annual Roth Conference

INCLINE VILLAGE, Nev., March 12, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Peter Garcia, PDL's vice president and chief financial officer, will participate in a series of investor meetings at the 31st Annual Roth Conference being held March 17-19 at the Ritz-Carlton Laguna Niguel in Dana Point, Calif. Mr. Garcia will also participate in a panel entitled "Searching for Deep Value in Pharma" being held on March 19 at 10:00 a.m. Pacific time.

An archived webcast of the panel presentation will be available within 24 hours on Roth Capital Market's website at http://www.wsw.com/webcast/roth33/. A copy of the PDL corporate presentation will be posted on the Company's website at pdl.com, in the Investor Relations section under "Events & Presentations."

About PDL BioPharma, Inc.
PDL BioPharma seeks to provide a significant return for its stockholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products. For more information please visit www.pdl.com

NOTE: PDL, PDL BioPharma, the PDL logo and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary, to PDL BioPharma, Inc. which reserves all rights therein.

PDL BioPharma, Inc. (PRNewsFoto/PDL BioPharma, Inc.)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-participate-at-31st-annual-roth-conference-300810675.html

SOURCE PDL BioPharma, Inc.

Company Codes: NASDAQ-NMS:PDLI

Back to news